The Brinter team is excited to announce that our CEO, Tom Alapaattikoski, will be attending the prestigious BIO New York conference in February.
“We are thrilled to be a part of the vibrant BIO community,” said Alapaattikoski. “As active members, we are looking forward to engaging in productive meetings and fostering partnerships that will help us advance our mission.”
Brinter’s attendance at BIO New York underscores our commitment to staying at the forefront of biotechnology and medical device innovation. The conference will provide an excellent platform for us to connect with potential partners and investors interested in our emerging BioMod technology.
